Health

Using price to avoid vaccine shortages

No one worries about vaccine supply—until there's a shortage. New research from Duke University's Fuqua School of Business studied the market tensions that can keep manufacturers out of the business and the price points ...

Other

Novo Nordisk US shares skid on drug review setback (Update)

Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.

page 2 from 2